Your Notifications
All done, no notifications

What is Glomerulonephritis?

Glomerulonephritis is a group of kidney conditions in which the glomeruli, the kidneys' tiny blood-filtering units, become inflamed and damaged. This can interfere with the kidneys' ability to remove waste and excess fluid while retaining essential proteins and blood cells. Depending on the cause and severity, glomerulonephritis may cause blood or protein in the urine, swelling, high blood pressure and reduced kidney function. Some forms are temporary, while chronic or rapidly progressive disease can lead to chronic kidney disease or kidney failure.

What is the Importance of Timely Treatment?

Timely evaluation and treatment can help identify the underlying cause, control inflammation, and reduce further kidney damage. Early management of high blood pressure, protein loss and fluid retention can help protect kidney function. In immune-mediated forms, appropriate treatment may reduce ongoing inflammation, while infection-related forms may require treatment of the underlying infection. Rapidly progressive glomerulonephritis requires urgent specialist assessment because kidney function can deteriorate quickly.

What are the Common Symptoms of Glomerulonephritis?

  • Blood in the urine, which may make urine appear pink, red or cola-coloured
  • Protein in the urine, which can cause foamy urine
  • Swelling around the eyes, face, ankles, feet or other parts of the body
  • High blood pressure
  • Reduced urine output
  • Increased urination at night
  • Fatigue and weakness
  • Loss of appetite
  • Nausea or vomiting
  • Shortness of breath, particularly when fluid accumulates
  • Headache or other symptoms related to uncontrolled blood pressure
  • Weight gain due to fluid retention

Causes and Risk Factors of Glomerulonephritis

Causes

  • Glomerulonephritis may develop from abnormal immune responses, certain infections, autoimmune diseases, or inherited conditions. In some cases, the exact cause is unknown.
  • Associated conditions include post-infectious glomerulonephritis, IgA nephropathy, lupus nephritis, anti-glomerular basement membrane (anti-GBM) disease and ANCA-associated vasculitis.
  • Certain medicines can cause or contribute to kidney inflammation in some patients.

Risk Factors

  • Recent infections associated with glomerulonephritis
  • Autoimmune diseases such as lupus or vasculitis
  • A family history of certain inherited kidney disorders
  • Genetic conditions affecting kidney function
  • Previous episodes of glomerulonephritis
  • Certain immune-system abnormalities or underlying systemic diseases

Latest Research and Technologies in the Treatment of Glomerulonephritis in the United Arab Emirates

  • Newer treatments are being developed for conditions such as IgA nephropathy, lupus nephritis and ANCA-associated vasculitis. These include targeted medicines that act on specific immune pathways and therapies designed to reduce protein loss in the urine and slow the decline in kidney function.

Treatment options for Glomerulonephritis

Immunosuppressive and Targeted Treatment : Depending on the underlying disease, treatment may include antimetabolites, alkylating agents or targeted biological therapies. Treatment should be based on the specific diagnosis, often supported by kidney biopsy and other investigations.

Kidney Transplantation : Patients with advanced kidney failure may need kidney replacement therapy, including hemodialysis or peritoneal dialysis. Kidney transplantation may be considered for eligible patients with irreversible kidney failure.

Cost Start From 30000Explore Options

  • Clinical assessment:
    • Medical and Nephrological Evaluation: A detailed history and physical examination assess swelling, urine changes, blood pressure, recent infections, autoimmune symptoms, medication exposure and family history of kidney disease.
    • Urine and Kidney Function Assessment: Urinalysis can detect blood, protein and other abnormalities. Urine albumin-to-creatinine or protein-to-creatinine ratios quantify protein loss, while blood tests, including serum creatinine and estimated glomerular filtration rate (eGFR), assess kidney function.
    • Blood and Immunological Assessment: Blood tests may include complete blood count, electrolytes, albumin, inflammatory markers and tests for the suspected underlying cause.
    • Kidney Biopsy: A kidney biopsy may be recommended when the diagnosis is uncertain, when an immune-mediated disease is suspected or when determining the specific type and severity of glomerular injury will influence treatment.
    • Assessment for Systemic Disease: Additional evaluation may identify autoimmune, infectious, genetic, or other systemic conditions associated with glomerulonephritis.
  • Imaging Tests:
    • Renal Ultrasound: Helps assess kidney size, structure and possible urinary tract abnormalities.
    • Doppler Ultrasound: May be used when renal blood flow or vascular abnormalities are clinically suspected.
    • CT Scan: May provide additional anatomical information when ultrasound findings are insufficient, or another abdominal or systemic condition is suspected.
    • MRI: May be used selectively when detailed soft-tissue or vascular assessment is required.
    • Chest Imaging: Chest X-ray or CT may be performed when lung involvement is suspected, particularly in systemic autoimmune diseases such as ANCA-associated vasculitis or anti-GBM disease.

MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive tele-rehabilitation services designed to support Neuromyelitis Optica patients in the United Arab Emirates. These services include:

  • Physical Activity and Exercise: Individualised physical activity can help maintain strength, mobility and cardiovascular health, with exercise intensity adjusted according to kidney function, blood pressure, anemia and overall health.
  • Glomerulonephritis treatment depends on the underlying disease and the severity of kidney involvement. ACE inhibitors or ARBs may help control blood pressure and reduce proteinuria. Doctors may prescribe diuretics to manage swelling and fluid retention. Some immune-mediated conditions require corticosteroids, immunosuppressive medicines or targeted biological therapies.

Instantly Connect with our Specialists

Doctor 1
Doctor 2
Doctor 3
Doctor 4
Doctor 5
Doctor 6
Doctor 7
Doctor 8

Hospitals for Glomerulonephritis in United Arab Emirates

Burjeel Medical City: Top Doctors, and Reviews
Burjeel Medical City

Abu Dhabi, United Arab Emirates

The Hospital owns an International Patient Services Team that is responsible to assist international patients with world-class healthcare, transportation arrangement, accommodation facilities, language interpreters, and much more. 

Burjeel Medical City (about 1.2 million square facilities)provides 7-star hospitality to its patients. It has the largest facility space bed among all the private hospitals. The Hospital consists of-

  • Large waiting areas and consultation rooms 
  • Spacious lobbies on each floor 
  • 338 Luxurious Patient Rooms 
  • 70 Ambulatory Rooms
  • Intensive Care Units
  • The Hospital comprises various centers, under Burjeel Cancer Institute- 
  • Breast Center
  • Uro-oncology Center
  • Surface Malignancy Center (HIPC)
  • Head & Oncology Center
  • Medical Oncology & Hematology Center and others
Message Us

241

PROCEDURE

1

DOCTORS IN 13 SPECIALITIES

20+

FACILITIES & AMENITIES

Our Services to better your experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Why Choose the United Arab Emirates for Glomerulonephritis Treatment?

  • Multidisciplinary Nephrology Care: Patients can access nephrologists, renal pathologists, rheumatologists, immunologists, and other specialists based on the underlying cause.
  • Advanced Diagnostic Facilities: Major centres may provide kidney biopsy, renal pathology, immunological testing, genetic evaluation and advanced kidney-function monitoring.
  • Disease-Specific Treatment: Treatment can be tailored to conditions such as IgA nephropathy, lupus nephritis, ANCA-associated vasculitis, infection-related glomerulonephritis and other glomerular disorders.
  • Comprehensive International Patient Support: Major hospitals may provide international-patient coordination, medical-record review, specialist consultations, treatment planning, accommodation assistance and follow-up coordination.

Frequently Asked Questions

Recovery depends on the underlying cause, whether the condition is acute or chronic and how much kidney damage has occurred. Some acute forms may improve over weeks or months after treating the underlying cause, while chronic glomerulonephritis may require long-term monitoring and treatment. Severe disease can result in persistent kidney impairment or kidney failure.

Yes. Most people with glomerulonephritis can walk and remain physically active. However, severe swelling, fatigue, anemia, high blood pressure or advanced kidney disease may reduce exercise tolerance. Adjust physical activity based on kidney function and medical advice.

Major UAE nephrology centres may provide kidney biopsy, advanced renal pathology, immunological testing, genetic testing, urine protein assessment, advanced imaging, dialysis and kidney transplantation. Treatment can be tailored to different forms of immune-mediated and other glomerular disease.

Many major UAE hospitals have international-patient departments that can assist with medical records, specialist consultations, treatment coordination, travel arrangements, accommodation and follow-up care.

Consider a nephrology centre with experience diagnosing and treating different forms of glomerular disease, with access to kidney biopsy, renal pathology, immunological testing, and multidisciplinary care. If advanced kidney disease is present, access to dialysis and kidney transplantation may also be important.

There is no single success rate for glomerulonephritis treatment because it includes many different diseases. Outcomes depend on the underlying cause, severity of kidney injury, amount of proteinuria, response to treatment and whether permanent kidney damage has developed.

Nephrologists at specialised UAE centres manage a wide range of glomerular diseases, including immune-mediated, infection-related and systemic forms of glomerulonephritis. Patients with complex disease may benefit from centres with renal pathology, immunology, rheumatology and kidney replacement therapy services.

Treatment risks depend on the cause and therapy used. Immunosuppressive medicines can increase infection risk and may cause adverse effects specific to the medication. Kidney biopsy carries procedural risks such as bleeding. Dialysis and transplantation also have treatment-specific risks. Discuss the potential risks and benefits with the treating nephrologist based on the specific diagnosis.

Seek urgent medical assessment for markedly reduced urine output, rapidly increasing swelling, shortness of breath, chest discomfort, severe headache or confusion. Blood in the urine accompanied by rapidly worsening kidney function or systemic symptoms also requires prompt assessment. Coughing up blood, particularly with kidney symptoms, can indicate a serious systemic condition and requires emergency evaluation.

Glomerulonephritis does not typically cause structural physical deformities. However, severe or prolonged disease may lead to chronic kidney disease, persistent swelling, muscle weakness, anaemia or reduced physical function. Complications depend on the underlying disease and the extent of kidney damage.

Yes. Fatigue, swelling, high blood pressure, dietary adjustments, medication side effects and repeated medical appointments can affect work, physical activity and emotional well-being. People with advanced kidney disease may also need dialysis or transplant assessment. Appropriate treatment, monitoring, nutritional support and rehabilitation can help maintain daily functioning.

Untreated or inadequately controlled glomerulonephritis can cause persistent proteinuria, high blood pressure, progressive loss of kidney function and chronic kidney disease. Some rapidly progressive forms can lead to kidney failure over a short period. Certain systemic forms may also affect organs such as the lungs, skin, joints or nervous system.

Not all forms can be prevented, particularly those associated with autoimmune or inherited conditions. Prompt evaluation and appropriate treatment of infections, management of underlying systemic diseases, avoiding unnecessary kidney-harming medicines, and regular follow-up may help reduce complications.

Glomerulonephritis can affect people of all ages. The likelihood of particular forms varies with age, infections, autoimmune conditions, inherited disorders and other medical factors. A family history may increase the likelihood of certain inherited kidney diseases, but many cases occur without a family history.

Author

Nimra Haseeb
Nimra Haseeb

MSc Biochemistry

4 Years of Experience

Miss Nimra Haseeb is a medical researcher and a scientific content writer. She holds a Bachelor’s degree in Biotechnology and a Master’s in Biochemistry from Integral University, Lucknow. With strong experience in healthcare research, she specializes in secondary research, clinical data analysis, and evidence-based medical writing. Her work focuses on transforming complex scientific and medical information into clear, accurate, and reliable healthcare content for patients and healthcare audiences. She is also experienced in interpreting medical studies and healthcare trends to deliver well-researched and informative content that supports better health awareness and decision-making. View More

Reviewer

Dr. Akash Khandelwal
Dr. Akash Khandelwal

Hematologist

9 Years of Experience

Dr. Akash Khandelwal is a distinguished Hematologist, Hemato-oncologist, and Bone Marrow Transplant (BMT) Physician with extensive training from the prestigious AIIMS New Delhi. His expertise encompasses a wide range of specialized techniques in bone marrow transplantation, including autologous and allogeneic transplants such as matched sibling donors, matched unrelated donors (MUD), and haploidentical donor transplants. Dr. Khandelwal has personally supervised and conducted over 100 bone marrow transplants. View More

Last Reviewed - January 2026